Evaluation and comparison of efficacy and safety of tirzepatide and semaglutide in patients with type 2 diabetes mellitus: a Bayesian network meta-analysis
These distinct mechanisms mean certain patients may respond better to non-GLP-1 options based on their underlying metabolic dysfunction and genetic predispositions
Kola B, Christ-Crain M, Lolli F, et al
As glucagon-like peptide-1 receptor agonists (GLP-1s) continue to be prescribed by providers, including FDA-approved commercial versions and compounded versions, we routinely are asked for guidance by providers around prescribing compounded drugs
While its gaining attention online, GLP-1 microdosing isnt medically recommended and can lead to reduced effectiveness or unpredictable outcomes without professional guidance
Transcriptomic analyses indicate broad influence over genes related to inflammation, repair, and cellular maintenance